MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed
The gap between patient need and treatment availability isn't just a healthcare problem
[Crossref] Madrid C, Aziza J, Hlali A, Bouferrache K, Abarca M (2010) Melanotic neuroectodermal tumour of infancy: A case report and review of the aetiopathogenic hypotheses
"KLOW" is the established community shorthand for this particular four-compound grouping (the letters trace to the constituents), and it is the name buyers most often search for
These enzymes can function in either direction, NADPH oxidation, or NADP + reduction dependent upon the redox state
Cell 44 , 759769 (2011)